Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Flexion Therapeutics (FLXN)

Flexion Therapeutics (FLXN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Flexion Therapeutics 10 MALL ROAD SUITE 301 BURLINGTON MA 01803 USA

P: 781-305-7777 F: 781-202-3399

Description:

Flexion Therapeutics, Inc. is a specialty pharmaceutical company. It is focused on the development and commercialization of injectable pain therapies. The Company is targeting anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It operates in the United States. The Company's product candidate, FX006, is an injectable intra-articular, meaning in the joint, sustained-release treatment for patients with moderate to severe OA pain. It is developing two additional product candidates, FX007 for post-operative pain and FX005 to treat end-stage OA patients. Flexion Therapeutics, Inc. is headquartered in Burlington, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 458,927
Shares Outstanding, K 50,321
Annual Sales, $ 85,550 K
Annual Net Income, $ -113,710 K
Last Quarter Sales, $ 28,180 K
Last Quarter Net Income, $ -22,210 K
60-Month Beta 1.53
% of Insider Shareholders 9.13%
% of Institutional Shareholders 90.01%
Float, K 45,727
% Float 90.87%

Growth:

1-Year Return -17.09%
3-Year Return -42.42%
5-Year Return -50.25%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -17.67%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/17/21
Earnings Per Share ttm -1.91
EPS Growth vs. Prev Qtr -36.36%
EPS Growth vs. Prev Year -20.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

FLXN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -44.26%
Profit Margin % -132.92
Net Margin % N/A
Debt/Equity N/A
Price/Sales 5.38
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -1.12
Interest Coverage -4.65
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar